Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Bjermer

Showing results (221-230 of 272) with videos related to

Pageof 28
Sort By:
American Journal of Respiratory Cell and Molecular Biology|March 31, 2021
Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary DiseaseSofia C Wijk, Pavan Prabhala, Barbora Michaliková, et al.
Respiratory Research|November 1, 2019
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trialFrançois Maltais, Leif Bjermer, Edward M Kerwin, et al.
The International Journal of Biochemistry & Cell Biology|December 16, 2016
Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosisGunilla Westergren-Thorsson, Ulf Hedström, Annika Nybom, et al.
Clinical and Translational Allergy|April 10, 2019
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task ForceNicolas Roche, Jonathan D Campbell, Jerry A Krishnan, et al.
Respiratory Research|December 13, 2025
Activation of regenerative pathways by exercise intervention in subjects with chronic obstructive pulmonary disease - a study protocolCaroline Larsson, Linda Elowsson, Ellen Tufvesson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY ModelSoham Shukla, Dhvani Shah, Alan Martin, et al.
European Clinical Respiratory Journal|March 15, 2018
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adultsCeleste Porsbjerg, Charlotte Ulrik, Tina Skjold, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2010
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airwaysJennifer Kearley, Jonas S Erjefalt, Cecilia Andersson, et al.
Respiratory Research|May 4, 2017
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary DiseaseJulie Weidner, Linnea Jarenbäck, Kim de Jong, et al.
International Journal of Molecular Sciences|August 21, 2019
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary FibrosisLinda Elowsson Rendin, Anna Löfdahl, Emma Åhrman, et al.
Pageof 28

Showing results (221-230 of 272) with videos related to

Sort By:
Pageof 28
American Journal of Respiratory Cell and Molecular Biology|March 31, 2021
Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary DiseaseSofia C Wijk, Pavan Prabhala, Barbora Michaliková, et al.
Respiratory Research|November 1, 2019
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trialFrançois Maltais, Leif Bjermer, Edward M Kerwin, et al.
The International Journal of Biochemistry & Cell Biology|December 16, 2016
Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosisGunilla Westergren-Thorsson, Ulf Hedström, Annika Nybom, et al.
Clinical and Translational Allergy|April 10, 2019
Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task ForceNicolas Roche, Jonathan D Campbell, Jerry A Krishnan, et al.
Respiratory Research|December 13, 2025
Activation of regenerative pathways by exercise intervention in subjects with chronic obstructive pulmonary disease - a study protocolCaroline Larsson, Linda Elowsson, Ellen Tufvesson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY ModelSoham Shukla, Dhvani Shah, Alan Martin, et al.
European Clinical Respiratory Journal|March 15, 2018
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adultsCeleste Porsbjerg, Charlotte Ulrik, Tina Skjold, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2010
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airwaysJennifer Kearley, Jonas S Erjefalt, Cecilia Andersson, et al.
Respiratory Research|May 4, 2017
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary DiseaseJulie Weidner, Linnea Jarenbäck, Kim de Jong, et al.
International Journal of Molecular Sciences|August 21, 2019
Matrisome Properties of Scaffolds Direct Fibroblasts in Idiopathic Pulmonary FibrosisLinda Elowsson Rendin, Anna Löfdahl, Emma Åhrman, et al.
Pageof 28